Abstract
A new series of anticancer agents are being investigated in the US following the isolation of combretastatin compounds from the South African Combretum caffrum tree. Synthetic analogues of combretastatin have shown significant cytotoxic activity in preliminary studies, and hopes are high for their clinical development as therapy for breast and ovarian cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
